Volcano (VOLC) CEO Scott Huennekens has predicted that the market for a test that shows whether...
Wednesday, January 9, 3:46 AM ETVolcano (VOLC) CEO Scott Huennekens has predicted that the market for a test that shows whether patients need heart stents could increase ten-fold to $2B within a decade. That would be a boon not only to Volcano, which sells the tests and could become a takeover target, but also to St. Jude Medical (STJ), which is the only other company in the game. Doctors are enthusiastic as data indicates they've been over-stenting.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles